Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,996,340 ordinary shares
- Purchase Date: September 26, 2025
- Price Range: 325.10p (Low) to 328.70p (High)
- Volume Weighted Average Price: 327.6614p
- Treasury Shares Held: 40,904,443 (post-settlement)
- Voting Shares Outstanding: 8,911,449,205
Material Changes
This transaction represents the second tranche of the share buyback programme announced on July 31, 2025. The purchase reduced the number of shares with voting rights and increased the company's treasury share holdings.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital allocation event.
Key Facts for Investor Verification
- Verify the total value of the buyback programme and the remaining authorization available after this tranche.
- Confirm the impact of the increased treasury share count on earnings per share (EPS) calculations in future reports.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular execution details.
- Check subsequent filings for the third tranche or completion of the buyback programme.